The CEO’s Communications Playbook: Build Trust in a Changing Vaccine Landscape
Wed, Sep 16
|
08:55 AM - 09:20 AM
123
Session details:
As vaccines faced increased scrutiny and shifting sentiment among policy makers and the public, Micron Biomedical was at a pivotal inflection point in advancing what is expected to be the world’s first commercially available needle-free dissolvable vaccine platform.
In the case study presentation, learn how the company:
-
Protected trust, reputation and enterprise value to external stakeholders while challenging the status quo, with a narrative about a new way to manufacture, transport and administer medicines against a rapidly changing vaccine landscape
-
Maintained one narrative at the center of the discussion on expanding access to medicines as the technology gained new applications, partners and commercial opportunities
-
Used strategic communications to build trust and become credible voices among key audiences on issues extending beyond vaccines to microdosing weight loss medications, biosecurity, preparedness and health equity
